38. Intralesional molecular heterogeneity in a BRAF-mutant BRAF inhibitor resistant melanoma: a case illustrating the challenges for personalised medicine — James S. Wilmott (2013) | RDL Network
38. Intralesional molecular heterogeneity in a BRAF-mutant BRAF inhibitor resistant melanoma: a case illustrating the challenges for personalised medicine
James S. Wilmott, Varsha Tembe, Julie R. Howle, Raghwa Sharma, John F. Thompson, Helen Rizos, Roger S. Lo, Richard Kefford, Richard A Scolyer, Georgina V. Long
Rachael Anforth, Tatiana Cristina Moraes Pinto Blumetti, Richard Kefford, R. Sharma, Richard A Scolyer, Steven Kossard, Georgina V. Long, Pablo Fernández‐Peñas
James S. Wilmott, Lauren E. Haydu, Alexander M. Menzies, Trina Lum, Jessica Hyman, John F. Thompson, Peter Hersey, Richard Kefford, Richard A Scolyer, Georgina V. Long
Emanuela Oldoni, Gary Saunders, Florence Biétrix, Laura García‐Bermejo, Anna Niehues, Peter A.C. ‘t Hoen, Jessica Nordlund, Marián Hajdúch, Andreas Scherer, Katja Kivinen, Esa Pitkänen, Tomi P. Mäkelä, Marta Gut, Serena Scollen, Łukasz Kozera, Manel Esteller, Leming Shi, Anton Ussi, Antoni L. Andreu, Alain J. van Gool
Discussion(0)
No comments yet. Be the first to comment.